Примери за използване на Increased risk of bleeding на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
These medicines may have side-effects, such as an increased risk of bleeding and ulcers.
Because of the potential for increased risk of bleeding, chronic NSAIDs(including COX-2 inhibitors)
Because of the potential for increased risk of bleeding, warfarin and Prasugrel Mylan should be co-administered with caution(see section 4.4).
Increased risk of bleeding and the appearance of bleeding complications in different organs and tissues;
Less common side effects may include an increased risk of bleeding and asthma from allergic reactions.
The authors noted that aspirin was associated with a significantly increased risk of bleeding, primarily in the gastrointestinal tract and brain.
The investigators noted that aspirin was associated with a significantly increased risk of bleeding, primarily in the gastrointestinal tract and brain.
Because of the potential for increased risk of bleeding, warfarin(or other coumarin derivatives)
Because of the potential for increased risk of bleeding, warfarin and Efient should be co-administered with caution(see section 4.4).
Table 3 shows coagulation test thresholds at trough that may be associated with an increased risk of bleeding(see section 5.1).
thrombolytic drugs including increased risk of bleeding(chap grate).
It should be explained to patients that Oncaspar should not be used at the same time as other medicines associated with an increased risk of bleeding(see section 2“Other medicines and Oncaspar”).
including anemia and an increased risk of bleeding or blood clotting.
Glybera must not be used in patients with immunodeficiency(weakened immunity), increased risk of bleeding and muscle disease.
One serious side effect of too much vitamin E is an increased risk of bleeding, especially in the brain.”.
Active bleeding or increased risk of bleeding because of haemostasis disorders and/or irreversible coagulation disorders.
Therefore, the use of prasugrel in patients at increased risk of bleeding should only be considered when the benefits in terms of prevention of ischaemic events are deemed to outweigh the risk of serious bleedings.
When desirudin is administered in patients with increased risk of bleeding complications, mild to moderate hepatic dysfunction and/or mild to moderate renal impairment,
An increased risk of bleeding may also be observed in patients who receive early administration of eptifibatide(e.g. upon diagnosis)
since these patients have an increased risk of bleeding complications.